These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2153006)
1. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE Am J Med; 1990 Jan; 88(1):36-42. PubMed ID: 2153006 [TBL] [Abstract][Full Text] [Related]
2. Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Winston DJ; Ho WG; Nakao SL; Gale RP; Champlin RE Am J Med; 1986 May; 80(5):884-90. PubMed ID: 3010716 [TBL] [Abstract][Full Text] [Related]
3. Norfloxacin for prevention of bacterial infections in granulocytopenic patients. Winston DJ; Ho WG; Champlin RE; Karp J; Bartlett J; Finley RS; Joshi JH; Talbot G; Levitt L; Deresinski S Am J Med; 1987 Jun; 82(6B):40-6. PubMed ID: 3037899 [TBL] [Abstract][Full Text] [Related]
4. Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia. Kern W; Kurrle E Infection; 1991; 19(2):73-80. PubMed ID: 2050424 [TBL] [Abstract][Full Text] [Related]
5. Ofloxacin for prevention of bacterial infections in granulocytopenic patients. Kern W; Kurrle E; Vanek E Infection; 1987; 15(6):427-33. PubMed ID: 3481358 [TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin for infection prophylaxis in granulocytopenic patients with acute leukemia. Cortellaro M; Cofrancesco E; Pasargiklian I; Bianchi R; Pozzoli E; Annaloro C; Ranzi ML; Mascheroni E; Polli N Haematologica; 1990; 75(6):541-5. PubMed ID: 2098296 [TBL] [Abstract][Full Text] [Related]
7. Oral ofloxacin therapy of infections due to multiply-resistant bacteria. Scully BE; Clynes N; Neu HC Diagn Microbiol Infect Dis; 1991; 14(5):435-41. PubMed ID: 1797458 [TBL] [Abstract][Full Text] [Related]
8. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702 [TBL] [Abstract][Full Text] [Related]
9. Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Karp JE; Dick JD; Angelopulos C; Charache P; Green L; Burke PJ; Saral R Am J Med; 1986 Aug; 81(2):237-42. PubMed ID: 3526884 [TBL] [Abstract][Full Text] [Related]
11. Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial. Attal M; Schlaifer D; Rubie H; Huguet F; Charlet JP; Bloom E; Lemozy J; Massip P; Pris J; Laurent G J Clin Oncol; 1991 May; 9(5):865-70. PubMed ID: 2016630 [TBL] [Abstract][Full Text] [Related]
12. Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study. Archimbaud E; Guyotat D; Maupas J; Ploton C; Nageotte A; Devaux Y; Thomas X; Fleurette J; Fiere D Eur J Cancer; 1991; 27(2):174-8. PubMed ID: 1827284 [TBL] [Abstract][Full Text] [Related]
13. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Rubin M; Hathorn JW; Marshall D; Gress J; Steinberg SM; Pizzo PA Ann Intern Med; 1988 Jan; 108(1):30-5. PubMed ID: 3337513 [TBL] [Abstract][Full Text] [Related]
14. Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure. Erjavec Z; de Vries-Hospers HG; van Kamp H; van der Waaij D; Halie MR; Daenen SM Scand J Infect Dis; 1994; 26(5):585-95. PubMed ID: 7855556 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic use of ofloxacin in granulocytopenic patients with hematological malignancies during post-remission chemotherapy. Tsutani H; Imamura S; Ueda T; Yoshida H; Iwasaki H; Fukushima T; Yoshimura T; Toyooka S; Nakamura T Intern Med; 1992 Mar; 31(3):319-24. PubMed ID: 1611181 [TBL] [Abstract][Full Text] [Related]
16. Prevention of bacterial and fungal infections in granulocytopenic patients. Verhoef J; Rozenberg-Arska M; Dekker AW Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1345-50. PubMed ID: 2680513 [TBL] [Abstract][Full Text] [Related]
17. Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy. Liang RH; Yung RW; Chan TK; Chau PY; Lam WK; So SY; Todd D Antimicrob Agents Chemother; 1990 Feb; 34(2):215-8. PubMed ID: 2327768 [TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of combined vancomycin and pefloxacine in gastrointestinal decontamination for preventing infections after chemotherapy-induced bone marrow aplasia. A randomized double-blind study]. Thomas X; Troncy J; Belhabri A; Thiebaut A; Bouheddou N; Michallet M; Fleurette J; Pivot C; Fiere D; Archimbaud E Presse Med; 2000 Oct; 29(32):1745-51. PubMed ID: 11098268 [TBL] [Abstract][Full Text] [Related]
19. Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study. Krupova Y; Novotny J; Sabo A; Mateicka F; Krcmery V Int J Antimicrob Agents; 1998 Nov; 10(4):313-6. PubMed ID: 9916907 [TBL] [Abstract][Full Text] [Related]
20. [Empirical treatment of febrile episodes in granulocytopenic patients with a combination of piperacillin and ofloxacin. Preliminary study]. Raffi F; Feve B; Tiab M; Brisseau JM; Reynaud AE; Grolleau JY Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):548-51. PubMed ID: 2385453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]